These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 7830796)
1. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Maddux BA; Sbraccia P; Kumakura S; Sasson S; Youngren J; Fisher A; Spencer S; Grupe A; Henzel W; Stewart TA Nature; 1995 Feb; 373(6513):448-51. PubMed ID: 7830796 [TBL] [Abstract][Full Text] [Related]
2. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus. Stefanović V; Antić S Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity. Belfiore A; Costantino A; Frasca F; Pandini G; Mineo R; Vigneri P; Maddux B; Goldfine ID; Vigneri R Mol Endocrinol; 1996 Nov; 10(11):1318-26. PubMed ID: 8923458 [TBL] [Abstract][Full Text] [Related]
4. Role of PC-1 in the etiology of insulin resistance. Goldfine ID; Maddux BA; Youngren JF; Trischitta V; Frittitta L Ann N Y Acad Sci; 1999 Nov; 892():204-22. PubMed ID: 10842664 [TBL] [Abstract][Full Text] [Related]
5. Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity. Chin CN; Dallas-Yang Q; Liu F; Ho T; Ellsworth K; Fischer P; Natasha T; Ireland C; Lu P; Li C; Wang IM; Strohl W; Berger JP; An Z; Zhang BB; Jiang G Eur J Pharmacol; 2009 Mar; 606(1-3):17-24. PubMed ID: 19374858 [TBL] [Abstract][Full Text] [Related]
7. Expression of the putative inhibitor of the insulin receptor tyrosine kinase PC-1 in dermal fibroblasts from patients with syndromes of severe insulin resistance. Whitehead JP; Humphreys PJ; Dib K; Goding JW; O'Rahilly S Clin Endocrinol (Oxf); 1997 Jul; 47(1):65-70. PubMed ID: 9302374 [TBL] [Abstract][Full Text] [Related]
11. Abnormal insulin receptor tyrosine kinase activity in kidney basolateral membranes from non-insulin-dependent diabetic rats. Grunberger G; Nagy K; Rempinski D; Levy J J Lab Clin Med; 1990 Jun; 115(6):704-11. PubMed ID: 2164078 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of disease: Ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors. Abate N; Chandalia M; Di Paola R; Foster DW; Grundy SM; Trischitta V Nat Clin Pract Endocrinol Metab; 2006 Dec; 2(12):694-701. PubMed ID: 17143316 [TBL] [Abstract][Full Text] [Related]
13. Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Maddux BA; Goldfine ID Diabetes; 2000 Jan; 49(1):13-9. PubMed ID: 10615944 [TBL] [Abstract][Full Text] [Related]
14. Urinary PC-1 activity in patients with type 1 diabetes mellitus. Stefanović V; Rajić M; Antić S; Mitić-Zlatković M; Stojiljković S; Ivić MA; Vlahović P Ann Clin Biochem; 2003 May; 40(Pt 3):235-8. PubMed ID: 12803834 [TBL] [Abstract][Full Text] [Related]
15. Comparison of alterations in insulin signalling pathway in adipocytes from Type II diabetic pregnant women and women with gestational diabetes mellitus. Tomazic M; Janez A; Sketelj A; Kocijancic A; Eckel J; Sharma PM Diabetologia; 2002 Apr; 45(4):502-8. PubMed ID: 12032625 [TBL] [Abstract][Full Text] [Related]
16. Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects: evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling. Frittitta L; Spampinato D; Solini A; Nosadini R; Goldfine ID; Vigneri R; Trischitta V Diabetes; 1998 Jul; 47(7):1095-100. PubMed ID: 9648833 [TBL] [Abstract][Full Text] [Related]
17. Insulin receptor tyrosine kinase activity is abnormal in circulating cells and cultured fibroblasts but normal in transformed lymphocytes from a type A insulin-resistant patient. Grunberger G; Comi RJ; Carpentier JL; Podskalny JM; McElduff A; Taylor SI; Gorden P J Lab Clin Med; 1988 Jul; 112(1):122-32. PubMed ID: 3292678 [TBL] [Abstract][Full Text] [Related]
18. Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo. Zhou HH; Chin CN; Wu M; Ni W; Quan S; Liu F; Dallas-Yang Q; Ellsworth K; Ho T; Zhang A; Natasha T; Li J; Chapman K; Strohl W; Li C; Wang IM; Berger J; An Z; Zhang BB; Jiang G Eur J Pharmacol; 2009 Aug; 616(1-3):346-52. PubMed ID: 19577557 [TBL] [Abstract][Full Text] [Related]
19. The development of insulin resistance with high fat feeding in rats does not involve either decreased insulin receptor tyrosine kinase activity or membrane glycoprotein PC-1. Ozel B; Youngren JF; Kim JK; Goldfine ID; Sung CK; Youn JH Biochem Mol Med; 1996 Dec; 59(2):174-81. PubMed ID: 8986641 [TBL] [Abstract][Full Text] [Related]
20. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Goldfine ID; Maddux BA; Youngren JF; Reaven G; Accili D; Trischitta V; Vigneri R; Frittitta L Endocr Rev; 2008 Feb; 29(1):62-75. PubMed ID: 18199690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]